RNA Deferred Revenue
Atrium Therapeutics Inc · Deferred Revenue
RNA Deferred Revenue
Latest reported$21.64Mperiod ending
RNA FY Deferred Revenue ($21.64M → $21.64M)
Annual deferred revenue
More history is needed to export this chart.
RNA deferred revenue history
Annual fiscal periods · USD. Dates are reporting period ends; fiscal years can differ from calendar years.
| Period ending | Deferred Revenue (USD) |
|---|---|
| 21,639,000 |